June 7, 2023

PiVOT to represent the Philippines at DIA 2023

Share on Facebook Share on Twitter Share on Mail

PiVOT, the largest and fastest-growing Philippine CRO, is excited to announce its participation as an exhibitor in the highly esteemed Drug Information Association (DIA) annual conference. As a global association committed to advancing healthcare product development, DIA is the premier event for professionals and thought leaders in the pharmaceutical, biotechnology, and medical device industries. Taking place in the dynamic city of Boston, Massachusetts in 2023, this conference offers a unique opportunity to network and gain insights into the latest industry trends and innovations.

Scheduled from June 25-29 2023, at the renowned Boston Convention and Exhibition Center (BCEC), the DIA Conference 2023 promises to be a transformative event for the healthcare sector. With its theme “Illuminate,” the conference aims to foster collaboration, drive innovation, and explore the latest advancements in drug development and regulatory science.

PiVOT is proud to be one of the healthcare companies in the Philippines. Other Philippine companies joining PiVOT at the DIA Conference include the Asian Eye Institute, a world-class eye institute that makes breakthrough technologies for eye care treatment available to all patients; Pi Health Manufacturing and Distribution Services Inc (PHMD), drugs, medical equipment, and supplies distributor and manufacturer; and the Medical Services of America (Philippines) Inc., a comprehensive range of cardiopulmonary services and equipment for hospitals and home-services patients.

PiVOT’s booth, located at Booth 124 near the DIA Innovation Theater #1, will showcase The Philippines as a top destination for Clinical Trials and Business Processing for Pharmacovigilance, Data Management, and Medical Communications. Not only is The Philippines recognized as the Call Center Capital of the World and a leader in IT & Business Processes, but it also boasts a population of 113 million, providing access to a vast pool of highly skilled English-speaking professionals who are essential for running successful clinical research. Conducting clinical trials in The Philippines is also cost-effective compared to other countries, making it an ideal choice for businesses looking to streamline their operations.

PiVOT’s participation in the DIA conference is a reflection of its commitment to advancing the impact of healthcare and improving patient outcomes. By collaborating with other healthcare companies from the Philippines, PiVOT is looking to enhance the quality of healthcare in the Philippines and all over the world.

PiVOT is thrilled to be exhibiting at the DIA 2023 conference and looks forward to engaging with attendees, sharing its expertise, and forging new partnerships with leading companies in the pharmaceutical, biotech, and medical device industries. With its commitment to quality, efficiency, and patient safety, PiVOT is well-positioned to deliver the innovative solutions that clients need to succeed in today’s rapidly evolving healthcare landscape.